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Appraisal Correspondence
Likelihood ratios ought to be interpreted in the context of 
the pre-test odds
I read with interest the paper by Prosser et al (2011) which 
nicely documented the likelihood ratios (LRs) associated 
with wrist examination. I question the application of the 
descriptors associated with the results, and feel that a central 
message of this paper could be read as ‘none of these tests 
are much use’. I believe this is a misrepresentation.
Clinicians want to know if, after doing some test, the 
patient is more or less likely to have some pathology, and 
by how much. The LR allows the clinician, by Bayesian 
reasoning, to arrive at the odds that some pathology is 
present after knowing both the result of the test and the 
pre-test odds (Altman and Bland 1994). There’s evidence a 
lot of clinicians don’t really understand this concept fully 
(Westover et al 2011) so we need to be careful in presenting 
data that can confuse this issue. I’m arguing that adding the 
descriptors ‘limited’ and ‘moderate’ (Prosser et al 2011) is 
not useful as a LR is no use to a clinician with a patient in 
front of them unless you also know the associated pre-test 
odds for that pathology. If you instead only rely on these 
descriptors, then it’s an easy step for the unwary clinician 
to think ‘this test is not worth doing’ since Prosser and 
colleagues said its use was ‘limited’ (Prosser et al 2011).
Say, based on the history, a patient has pre-test odds of 
50% of having a tear in their TFCC, ie, an even money 
bet. Positive and negative MRI ﬁndings are associated with 
LRs of about 5.6 and 0.2 respectively (Prosser et al 2011) 
which means that the clinician would then be able to say, 
‘after doing the test, the odds will be either 84% or 17% 
that the patient has the pathology.’ The physio can then tell 
her patient if the MRI is positive that there are ‘more than 4 
chances in 5 of having a TFCC tear’ or (after a negative test) 
‘less than 2 chances in 5 of a tear’. She has gone from a coin 
toss to being right about 80% of the time, and if the patient 
wants to know if they should see a surgeon or not, she can 
now help them make their decision.
So you’re now saying it’s a ‘good’ test then? Well, no. 
With the same example, but pre-test odds of 10%, we have 
post-test odds of 38% and 2% respectively for positive and 
negative tests – ie, despite the test outcome I still think 
the patient probably doesn’t have the pathology. 90% pre-
test odds would be associated with post-test odds of 98% 
and 64%, ie, I still think that they probably do have this 
pathology, I’m just betting different amounts of money on 
it. Claiming these tests are ‘good’ or ‘bad’ because of their 
LR is misleading since their clinical interpretation relies 
equally on the pre-test odds (except for LRs of 1 which are 
genuinely useless as they don’t alter the post-test odds at 
all.) Beyond that, we can only really use these LR numbers 
in isolation to compare the utility of two different tests, ie, 
‘how much better is this test than that test?’ Stating that the 
test is of ‘limited’ or ‘moderate’ utility without reference 
to the pre-test odds is essentially trying to describe if some 
number (which can range from 0 to 1, or 1 to inﬁnity, 
Altman and Bland 1994) is ‘large’ or ‘small’. This paper 
has documented (very well in my opinion) LR for these 
clinical tests, and I think this is how the data should have 
been presented.
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